{"database": "press", "table": "releases", "rows": [["https://www.wicker.senate.gov/public/index.cfm/press-releases?ContentRecord_id=A3E0D7B2-5DA3-4C6D-8135-C751D95D2649", "National Institute on Aging Advances Wickers EUREKA Plan", "2017-11-07", "2017", "2017-11", "Republican", "House", "MS", "Roger Wicker", "W000437", "www.wicker.senate.gov", null, null, "legacy", "WASHINGTON \u2013 The National Institute on Aging (NIA) has begun the process of implementing U.S. Senator Roger Wicker\u2019s, R-Miss., proposal to create prize-based competitions in the fight against Alzheimer\u2019s disease. Wicker\u2019s \u201cEnsuring Useful Research Expenditures is Key for Alzheimer\u2019s (EUREKA) Act\u201d became law in December 2016 as part of the \u201c21st Century Cures Act.\u201d \u201cThis is a time of tremendous hope for millions of Americans who suffer from Alzheimer\u2019s and other forms of dementia,\u201d Wicker said. \u201cI believe that prize-based competitions, which pay only for success, will help spur advancements in technology and increase our understanding of these terrible afflictions.\u201d NIA released a Request for Information on November 2 to collect public input and suggestions on the development of the EUREKA prize for Alzheimer's disease research.\u00a0 Additional background information is provided in the RFI.\u00a0 All comments should be submitted electronically by email to NIAPrizeInput@nih.gov by 11:59:59 pm (ET) on December 31, 2017. The plan does not replace other funding and research initiatives for Alzheimer\u2019s but adds another route for breakthroughs. The law requires the agency to establish prize challenges to combat our nation\u2019s most devastating and costliest diseases, including Alzheimer\u2019s. Prize challenges enable government sponsors to pay only when a prize team achieves specified goals or milestones. Although funds will be authorized and reserved for awards, prizes will only be granted when teams achieve clearly defined objectives, making the \u201cEUREKA Act\u201d a cost-effective tool to spur leading-edge research. NIH has set a goal of curing Alzheimer\u2019s by 2025. Today, Alzheimer\u2019s is the most expensive disease in America and has a 100 percent fatality rate. According to a report released earlier this year, caring for people with Alzheimer\u2019s disease and other dementias is estimated to cost the United States $259 billion in 2017, with one in five Medicare dollars spent on an Alzheimer\u2019s victim. Unless a cure is found for Alzheimer\u2019s, treatment costs are expected to grow to an estimated $1.1 trillion by 2050.\u00a0In Mississippi, 12 percent of senior citizens have Alzheimer\u2019s. The number of victims is expected to rise 22.6 percent by 2025, increasing from 53,000 to 65,000. \u201cEUREKA\u201d was supported by more than 70 organizations, including the XPRIZE Foundation, Alzheimer\u2019s Foundation of America, UsAgainstAlzheimer\u2019s, Alzheimer's Association, Eli Lilly and Company, BrightFocus Foundation, and the MIND Center at the University of Mississippi Medical Center.", 1, "2026-03-30T12:14:52Z", "2026-03-30T12:14:52Z"]], "columns": ["url", "title", "date", "year", "month", "party", "chamber", "state", "member_name", "bioguide_id", "domain", "scraper", "source", "date_source", "text", "has_text", "collected_at", "updated_at"], "primary_keys": ["url"], "primary_key_values": ["https://www.wicker.senate.gov/public/index.cfm/press-releases?ContentRecord_id=A3E0D7B2-5DA3-4C6D-8135-C751D95D2649"], "units": {}, "query_ms": 1.9102119840681553, "source": "dwillis/congress-press", "source_url": "https://github.com/dwillis/congress-press", "license": "MIT", "license_url": "https://github.com/dwillis/congress-press/blob/main/LICENSE"}